Literature DB >> 31545310

Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentary.

Ruben A Mesa1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31545310      PMCID： PMC8916229     

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

Authors:  Srdan Verstovsek; Alessandro M Vannucchi; Martin Griesshammer; Tamas Masszi; Simon Durrant; Francesco Passamonti; Claire N Harrison; Fabrizio Pane; Pierre Zachee; Keita Kirito; Carlos Besses; Masayuki Hino; Beatriz Moiraghi; Carole B Miller; Mario Cazzola; Vittorio Rosti; Igor Blau; Ruben Mesa; Mark M Jones; Huiling Zhen; Jingjin Li; Nathalie Francillard; Dany Habr; Jean-Jacques Kiladjian
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

2.  Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

Authors:  Alessandro M Vannucchi; Jean Jacques Kiladjian; Martin Griesshammer; Tamas Masszi; Simon Durrant; Francesco Passamonti; Claire N Harrison; Fabrizio Pane; Pierre Zachee; Ruben Mesa; Shui He; Mark M Jones; William Garrett; Jingjin Li; Ulrich Pirron; Dany Habr; Srdan Verstovsek
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

3.  A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.

Authors:  Lucia Masarova; Srdan Verstovsek; Juliana E Hidalgo-Lopez; Naveen Pemmaraju; Prithviraj Bose; Zeev Estrov; Elias J Jabbour; Farhad Ravandi-Kashani; Koichi Takahashi; Jorge E Cortes; Jing Ning; Maro Ohanian; Yesid Alvarado; Lingsha Zhou; Sherry Pierce; Romany Gergis; Keyur P Patel; Rajyalakshmi Luthra; Tapan M Kadia; Courtney D DiNardo; Gautam Borthakur; Kapil Bhalla; Guillermo Garcia-Manero; Carlos E Bueso-Ramos; Hagop M Kantarjian; Naval Daver
Journal:  Blood       Date:  2018-09-05       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.